Scientific Sessions 2025  /  Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential with SGLT2 Inhibitors. Provided by Clinical Care Options. This activity is supported by an educational grant from Boehringer Ingelheim & Eli Lilly.  /  Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential with SGLT2 Inhibitors. Provided by Clinical Care Options. This activity is supported by an educational grant from Boehringer Ingelheim & Eli Lilly.
Logo

American Heart Association

  70
  0

Final ID:

Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential with SGLT2 Inhibitors. Provided by Clinical Care Options. This activity is supported by an educational grant from Boehringer Ingelheim & Eli Lilly.

  • Butler, Javed  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Gluckman, Ty  ( Providence Heart Institute , Portland , Oregon , United States )
    • Author Disclosures:
    Javed Butler: DO have relevant financial relationships ; Consultant:Abbott :Active (exists now) ; Consultant:Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, NovoNordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, Zoll:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:CVRx:Active (exists now) ; Consultant:CSL Vifor:Active (exists now) ; Consultant:Cardior:Active (exists now) ; Consultant:Cardiac Dimension:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:AskBio:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:American Regent:Active (exists now) ; Consultant:Adaptyx:Active (exists now) | Ty Gluckman: DO have relevant financial relationships ; Consultant:OptumRx:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential with SGLT2 Inhibitors. Provided by Clinical Care Options. This activity is supported by an educational grant from Boehringer Ingelheim & Eli Lilly.

Saturday, 11/08/2025 , 07:00PM - 08:30PM

Industry Satellite Symposia

More abstracts from these authors:
QCOR Community: How to Engage and Succeed

Butler Javed

Centralized Population Health Management

Ambrosy Andrew, Gluckman Ty

You have to be authorized to contact abstract author. Please, Login
Not Available